Cancer Therapeutics
Cancer Pharmacology is the study of the effects and mechanisms of drugs used in the treatment of cancer. This research aims to improve the safety and efficacy of cancer treatments by developing new and innovative drugs, as well as optimizing existing ones. Cancer pharmacologists work to understand the molecular and cellular targets of cancer drugs, how drugs interact with these targets, and how these interactions impact the efficacy and toxicity of treatments. This research also involves studying how drugs are metabolized in the body, and how individual patient factors, such as genetics and underlying medical conditions, can affect drug response. At CRTOH, Cancer Pharmacology research is focused on developing personalized and effective treatments, improving patient outcomes and advancing the field of cancer research.
Our researchers
Grid view
-
-
Prof. Carole Bourquin
-
-
Prof. Valentina Garibotto
Head of the Division of Nuclear Medicine and Molecular imaging – HUG
-
Prof. Francesco Luigi Gervasio
Biological and Pharmaceutical Modelling, School of Pharmaceutical Sciences
-
Prof. Vladimir Katanaev
Oncogenic signaling pathways: from fundamental research to drug discovery, Group leader
-
-
-
Prof. Denis Migliorini
Head, Neuro Oncology Unit, HUG
Assistant Professor, Department of Oncology, UNIGE -
-
-
Dr. Federico Simonetta
Chef de Clinique Scientifique Oncology, Division of Hematology
Dr. Federico Simonetta
-
-
-
-
List view
-
Borchard Gerrit
Biopharmaceuticals, Group Leader, CRTOH associate member
-
Bourquin Carole
Immunopharmacology of Cancer, Group leader
-
Cuendet Muriel
Pharmacognosy Group leader, CRTOH associate member
School of pharmaceutical sciences,Faculty of Science -
Garibotto Valentina
Head of the Division of Nuclear Medicine and Molecular imaging – HUG
-
Gervasio Francesco Luigi
Biological and Pharmaceutical Modelling, School of Pharmaceutical Sciences
B09.1716.A -
Katanaev Vladimir
Oncogenic signaling pathways: from fundamental research to drug discovery, Group leader
-
Mach Nicolas
Translational Research in Oncology, Group Leader
-
Meraldi Patrick
Cell Division and Cancer, Group Leader
-
Migliorini Denis
Head, Neuro Oncology Unit, HUG
Assistant Professor, Department of Oncology, UNIGE -
Nowak-Sliwinska Patrycja
Molecular Pharmacology, Group leader
-
Serre-Beinier Véronique
Head of Division / Biologist
D02.1547.A -
Simonetta Federico
Chef de Clinique Scientifique Oncology, Division of Hematology
-
Tamburini Jérôme
Lymphomas and leukaemias, Group Leader
-
Villard Jean
HUG Diagnostic, Affiliated member PATIM
-
Vozenin Marie-Catherine
Oncology Department, HUG
-
Walker Paul
Immunobiology of Brain Tumours, group leader